Establishment of a cloned line of Lewis lung carcinoma cells adapted to cell culture, Cancer Letters, vol.11, issue.1, pp.63-73, 1980. ,
DOI : 10.1016/0304-3835(80)90130-5
ANGIOGENESIS AND TUMOR METASTASIS, Annual Review of Medicine, vol.49, issue.1, pp.407-424, 1998. ,
DOI : 10.1146/annurev.med.49.1.407
Hypoxia-induced metastasis of human melanoma cells: involvement of vascular endothelial growth factor-mediated angiogenesis, British Journal of Cancer, vol.80, issue.11, pp.1697-1707, 1999. ,
DOI : 10.1038/sj.bjc.6690586
Pathophysiology of tumor angiogenesis and its relevance in renal cell cancer, Anticancer Res, vol.19, pp.1557-1561, 1999. ,
Intra-tumoural microvessel density in human solid tumours, British Journal of Cancer, vol.5, issue.10, pp.1566-1577, 2002. ,
DOI : 10.1038/sj.bjc.6600315
MR angiogenesis imaging with Robo4- vs. ??V??3-targeted nanoparticles in a B16/F10 mouse melanoma model, The FASEB Journal, vol.24, issue.11, pp.4262-4270, 2010. ,
DOI : 10.1096/fj.10-157933
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3066028
Involvement of tumor cell integrin alpha v beta 3 in hematogenous metastasis of human melanoma cells, Clinical and Experimental Metastasis, vol.19, issue.5, pp.427-436, 2002. ,
DOI : 10.1023/A:1016377114119
An integrin ??v??3???c-Src oncogenic unit promotes anchorage-independence and tumor progression, Nature Medicine, vol.63, issue.10, pp.1163-1169, 2009. ,
DOI : 10.1038/nm.2009
Cell Adhesion Molecule Expression within the Microvasculature of Human Colorectal Malignancies, Clinical Immunology and Immunopathology, vol.72, issue.1, pp.129-136, 1994. ,
DOI : 10.1006/clin.1994.1116
The increased expression of adhesion molecules ICAM-3, E- and P-selectins on breast cancer endothelium, The Journal of Pathology, vol.61, issue.4, pp.369-376, 1995. ,
DOI : 10.1002/path.1711770407
Targeting selectins and selectin ligands in inflammation and cancer, Expert Opinion on Therapeutic Targets, vol.95, issue.11, pp.1473-1491, 2007. ,
DOI : 10.1158/1078-0432.CCR-05-1131
E-selectin as a target for drug delivery and molecular imaging, Journal of Controlled Release, vol.158, issue.2, pp.194-206, 2012. ,
DOI : 10.1016/j.jconrel.2011.09.084
The ??1??1 and ??2??1 Integrins Provide Critical Support for Vascular Endothelial Growth Factor Signaling, Endothelial Cell Migration, and Tumor Angiogenesis, The American Journal of Pathology, vol.160, issue.1, pp.195-204, 2002. ,
DOI : 10.1016/S0002-9440(10)64363-5
Enhanced pathological angiogenesis in mice lacking ??3 integrin or ??3 and ??5 integrins, Nature Medicine, vol.8, issue.1, pp.27-34, 2002. ,
DOI : 10.1038/nm0102-27
Inhibitors of integrins, Current Opinion in Pharmacology, vol.2, issue.4, pp.394-402, 2002. ,
DOI : 10.1016/S1471-4892(02)00175-3
Adhesion molecules and gene transfer, Advanced Drug Delivery Reviews, vol.44, issue.2-3, pp.135-152, 2000. ,
DOI : 10.1016/S0169-409X(00)00091-0
Improved gene transfer efficiency to primary and established human pancreatic carcinoma target cells via epidermal growth factor receptor and integrin-targeted adenoviral vectors, Gene Ther, vol.8, pp.969-976, 2001. ,
Immunotargeting of liposomes to activated vascular endothelial cells: A strategy for site-selective delivery in the cardiovascular system, Proceedings of the National Academy of Sciences, vol.94, issue.16, pp.8795-8800, 1997. ,
DOI : 10.1073/pnas.94.16.8795
Targeted antiangiogenic therapy for cancer using Vitaxin: a humanized monoclonal antibody to the integrin alphavbeta3, Clin Cancer Res, vol.6, pp.3056-3061, 2000. ,
Inhibition of angiogenesis and tumor growth by SCH221153, a dual alpha(v)beta3 and alpha(v)beta5 integrin receptor antagonist, Cancer Res, vol.61, pp.2232-2238, 2001. ,
Integrins in cancer: biological implications and therapeutic opportunities, Nature Reviews Cancer, vol.13, issue.1, pp.9-22, 2010. ,
DOI : 10.1038/nrc2748
Cilengitide: The First Anti-Angiogenic Small Molecule Drug Candidate. Design, Synthesis and Clinical Evaluation, Anti-Cancer Agents in Medicinal Chemistry, vol.10, issue.10, 2010. ,
DOI : 10.2174/187152010794728639
Integrin Targeting for Tumor Optical Imaging, Theranostics, vol.1, pp.102-126, 2011. ,
DOI : 10.7150/thno/v01p0102
Inhibition of Tumor Angiogenesis and Melanoma Growth by Targeting Vascular E-Selectin, Annals of Surgery, vol.254, issue.3, pp.450-456, 2011. ,
DOI : 10.1097/SLA.0b013e31822a72dc
In vivo characterization of a doxorubicin resistant B16 melanoma cell line, British Journal of Cancer, vol.54, issue.2, pp.223-233, 1986. ,
DOI : 10.1038/bjc.1986.166
Antitumor activity of intoplicine (RP 60475, NSC 645008), a new benzo-pyrido-indole: evaluation against solid tumors and leukemias in mice, Investigational New Drugs, vol.34, issue.Supplement 1, pp.263-277, 1993. ,
DOI : 10.1007/BF00874425
Experimental antitumor activity of taxotere (RP 56976, NSC 628503), a taxol analogue, Cancer Res, vol.51, pp.4845-4852, 1991. ,
Toxicity and anticancer activity of a new triazine antifolate, 1982. ,
Studies correlating the growth rate of a tumor and its metastases and providing evidence for tumor-related systemic growth-retarding factors, Cancer Res, vol.32, pp.374-379, 1972. ,
undifferentiated Highly metastatic: >90 to lungs % ,
mucinous, drug insensitive Moderately to highly metastatic: >80 to lungs and to lymph nodes %, pp.26-57 ,